Stock KDEV KAROLINSKA DEVELOPMENT AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Karolinska Development AB

Equities

KDEV

SE0002190926

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm
Other stock markets
 11:21:17 2024-04-26 am EDT 		5-day change 1st Jan Change
1.57 SEK +3.43% Intraday chart for Karolinska Development AB +3.43% -7.54%
Apr. 26 Karolinska Development AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 16 Karolinska Development AB Announces That Björn Cochlovius Has Declined Re-Election CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 619.2 315.8 933.2 466.8 458.2 423.6 - -
Enterprise Value (EV) 1 619.2 315.8 933.2 466.8 458.2 364.6 381.6 399.6
P/E ratio 0.86 x -1.53 x - -5.09 x 84.9 x -26.2 x -26.2 x -
Yield - - - - - - - -
Capitalization / Revenue 182 x - 430 x 203 x - 212 x 212 x 212 x
EV / Revenue 182 x - 430 x 203 x - 182 x 191 x 200 x
EV / EBITDA - - 5.78 x -5.38 x - -14 x -14.7 x -15.4 x
EV / FCF - - - -14.3 x - -10.1 x -14.7 x -15.4 x
FCF Yield - - - -6.97% - -9.87% -6.81% -6.51%
Price to Book - - 0.97 x 0.38 x - 0.34 x 0.35 x 0.35 x
Nbr of stocks (in thousands) 175,421 175,421 175,421 269,833 269,833 269,833 - -
Reference price 2 3.530 1.800 5.320 1.730 1.698 1.570 1.570 1.570
Announcement Date 2/13/20 2/11/21 2/25/22 2/17/23 2/16/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3.4 - 2.17 2.3 - 2 2 2
EBITDA 1 - - 161.4 -86.73 - -26 -26 -26
EBIT 1 - - 160.7 -87.42 - -26 -26 -26
Operating Margin - - 7,405.53% -3,800.91% - -1,300% -1,300% -1,300%
Earnings before Tax (EBT) 1 - - 170.8 -88.12 - -17 -16 -
Net income 1 - -207.5 170.8 -88.12 5.386 -17 -16 -15
Net margin - - 7,870.97% -3,831.39% - -850% -800% -750%
EPS 2 4.100 -1.180 - -0.3400 0.0200 -0.0600 -0.0600 -
Free Cash Flow 1 - - - -32.53 - -36 -26 -26
FCF margin - - - -1,414.52% - -1,800% -1,300% -1,300%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 2/13/20 2/11/21 2/25/22 2/17/23 2/16/24 - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 - - - - - 59 42 24
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - - - -32.5 - -36 -26 -26
ROE (net income / shareholders' equity) - - 19.3% - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 - - 5.500 4.600 - 4.560 4.490 4.430
Cash Flow per Share - - - - - - - -
Capex 1 - - 3.12 - - - - -
Capex / Sales - - 143.82% - - - - -
Announcement Date 2/13/20 2/11/21 2/25/22 2/17/23 2/16/24 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
KAROLINSKA DEVELOPMENT AB Stock Karolinska Development AB
-7.54% 38.64M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. KDEV Stock
  4. Financials Karolinska Development AB